These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 12101720)

  • 21. [Concurrent radiotherapy and chemotherapy for non-small-cell lung cancer--continuous infusion of low dose cisplatin and 5-FU].
    Itoh Y; Fuwa N; Kikuchi Y; Matsumoto A; Muramoto H; Kato E; Shinoda M; Sugiura T
    Gan To Kagaku Ryoho; 1996 Oct; 23(12):1721-4. PubMed ID: 8886053
    [No Abstract]   [Full Text] [Related]  

  • 22. [New treatment strategy for stage III non-small-cell lung cancer].
    Yoh K; Kubota K
    Nihon Rinsho; 2002 May; 60 Suppl 5():485-9. PubMed ID: 12101719
    [No Abstract]   [Full Text] [Related]  

  • 23. Scalpels, beams, drugs, and dreams: challenges of stage IIIA-N2 non-small-cell lung cancer.
    Johnson DH; Rusch VW; Turrisi AT
    J Natl Cancer Inst; 2007 Mar; 99(6):415-8. PubMed ID: 17374824
    [No Abstract]   [Full Text] [Related]  

  • 24. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of non-resectable stage III non-small cell lung cancer].
    Fournel P
    Rev Pneumol Clin; 2004 Nov; 60(5 Pt 2):3S43-7. PubMed ID: 15536352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
    Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of small cell lung cancer].
    Ueoka H; Ohnoshi T
    Gan To Kagaku Ryoho; 1994 Nov; 21(15):2571-7. PubMed ID: 7979415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controversies in the nonsurgical treatment of stage III non-small cell lung cancer.
    Hazuka MB; Bunn PA
    Am Rev Respir Dis; 1992 Apr; 145(4 Pt 1):967-77. PubMed ID: 1313216
    [No Abstract]   [Full Text] [Related]  

  • 29. Non-small-cell lung cancer: multimodality approach in stage-III resectable disease.
    Thomas M; Hoffknecht P; Droege C; Baisch A; Reinmuth N; Kreuter M; Lange T; Berdel WE
    Lung Cancer; 2004 Aug; 45 Suppl 2():S99-105. PubMed ID: 15552789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined modality therapy for stage III non-small cell lung cancer.
    Stinchcombe TE; Fried D; Morris DE; Socinski MA
    Oncologist; 2006; 11(7):809-23. PubMed ID: 16880240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Management of non-small-cell lung carcinoma (NSCLC) of stage III B].
    Koukourakis M
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S33-6. PubMed ID: 11924241
    [No Abstract]   [Full Text] [Related]  

  • 32. Phase I trial of radiation with concurrent and consolidation pemetrexed and cisplatin in patients with unresectable stage IIIA/B non-small-cell lung cancer.
    Brade A; Bezjak A; MacRae R; Laurie S; Sun A; Cho J; Leighl N; Pearson S; Southwood B; Wang L; McGill S; Iscoe N; Shepherd FA
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1395-401. PubMed ID: 20605367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multimodality approach to management of stage III non-small cell lung cancer.
    Scarpaci A; Mitra P; Jarrar D; Masters GA
    Surg Oncol Clin N Am; 2013 Apr; 22(2):319-28. PubMed ID: 23453337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The role of surgery for the management of resectable stage III non-small cell lung cancer].
    Rades D
    Strahlenther Onkol; 2016 Aug; 192(8):592-4. PubMed ID: 27334274
    [No Abstract]   [Full Text] [Related]  

  • 35. Multimodal treatment with surgical resection for stage IIIB non-small-cell lung cancer.
    Pennathur A; Luketich JD
    Lancet Oncol; 2009 Aug; 10(8):742-3. PubMed ID: 19647194
    [No Abstract]   [Full Text] [Related]  

  • 36. [Non surgical new treatment modalities for lung cancer].
    Kobayashi K
    Nihon Geka Gakkai Zasshi; 2002 Feb; 103(2):217. PubMed ID: 11904982
    [No Abstract]   [Full Text] [Related]  

  • 37. [Bronchial cancer: the initial assessment and therapeutic principles].
    Lemarié E
    Pneumoftiziologia; 1991; 40(4):19-25. PubMed ID: 1668795
    [No Abstract]   [Full Text] [Related]  

  • 38. The current state of the art in treating stage IIIA (N2) lung cancer.
    Martini N
    Ann Oncol; 1998 Mar; 9(3):243-5. PubMed ID: 9602255
    [No Abstract]   [Full Text] [Related]  

  • 39. The use of combination immunotherapies as front-line therapy for non-small-cell lung cancer.
    Santana-Davila R; Chow LQ
    Future Oncol; 2018 Feb; 14(3):191-194. PubMed ID: 29334785
    [No Abstract]   [Full Text] [Related]  

  • 40. Radiation enhanced efficiency of combined electromagnetic hyperthermia and chemotherapy of lung carcinoma using cisplatin functionalized magnetic nanoparticles.
    Babincová M; Kontrisova K; Durdík S; Bergemann C; Sourivong P
    Pharmazie; 2014 Feb; 69(2):128-31. PubMed ID: 24640602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.